欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
AT/H/0895/001
药品名称
Lisinopril 5 mg tablets
活性成分
Lisinopril dihydrate 5.0 mg
剂型
Tablet
上市许可持有人
1A Pharma AG Stella-Klein-Löw-Weg 17 1020 Wien Austria
参考成员国 - 产品名称
Austria (AT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Belgium (BE)
Netherlands (NL)
Ireland (IE)
Italy (IT)
许可日期
2008/04/05
最近更新日期
2024/11/29
药物ATC编码
C09AA03 lisinopril
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final Labelling
|
final_common_LAB_AT_H_0895_001_003_IB_058_clean
Date of last change:2024/09/06
Final Labelling
|
final_common_LAB_AT_H_0895_001_003_IB_058_tracked
Date of last change:2024/09/06
Final PL
|
final_common_PIL_AT_H_0895_001_003_IB_058_clean
Date of last change:2024/09/06
Final PL
|
final_common_PIL_AT_H_0895_001_003_IB_058_tracked
Date of last change:2024/09/06
Final SPC
|
final_common_SmPC_AT_H_XXXX_WS_0264_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase